ICON experts frequently author or contribute to industry trade press. The following are some recent articles.
Stakeholder Dialogue in Europe’s Adaptive Pathways Pilot
The AP approach is designed for products in therapeutic areas of high unmet need and for which it may be difficult to generate clinical data via the regular route.
Adaptive Designs: Smarter Development Programmes for Oncology
Parvin Fardipour and Alan Phillips review the different types of adaptive trial designs that have been deployed in oncology trials to good effect and more.
Challenges in Clinical Trials
Steve Cutler, outlines some of the challenges to successful clinical trials in this PharmaTimes artice.
Device Certification and Recertification
A three-step approach to identify products for compliance with the new MDR and IVDR.
Evaluation of Psoriasis Patient Attitudes in their Choice of Treatments
How psoriasis patients’ prior treatment history impacts future treatment choices.
A thought leadership article on outsourcing models being deployed in the pharmaceutical industry, in particular discussing the role of Functional Service Provision
Four Challenges Under the New EU MDR and IVDR
The regulations will take effect across all member EU states affecting all medical and diagnostic device companies within the world’s second largest device market
Blockchain: The Future for Research Data Integrity?
Blockchain could eventually lead to a "paradigm shift" shift in which people expect their digital data -- including health data -- to be easily accessible, private and secure.
Meet Demand for Real World Evidence
ICON and Practice Fusion have teamed up to meet the expanding demand for real world evidence
PharmaVOICE 100 Awards
ICON experts Dr. Nuala Murphy and Ramita Tandon have been recognised in the Commanders & Chiefs and Mentors categories respectively in the PharmaVOICE 100 Awards